Long-term Efficacy of Dupilumab in Papulo-erythroderma of Ofuji
DOI:
https://doi.org/10.2340/actadv.v104.40220Keywords:
papulo-erythroderma of Ofuji, dupilumabAbstract
Abstract is missing (Short communication)
Downloads
References
Ofuji S, Furukawa F, Miyachi Y, Ohno S. Papuloerythroderma. Dermatologica 1984; 169: 125-130.
https://doi.org/10.1159/000249586 DOI: https://doi.org/10.1159/000249586
Torchia D, Miteva M, Hu S, Cohen C, Romanelli P. Papuloerythroderma 2009: two new cases and systematic review of the worldwide literature 25 years after its identification by Ofuji et al. Dermatol Basel Switz 2010; 220: 311-320.
https://doi.org/10.1159/000301915 DOI: https://doi.org/10.1159/000301915
Shah M, Reid WA, Layton AM. Cutaneous T-cell lymphoma presenting as papuloerythroderma: a case and review of the literature. Clin Exp Dermatol 1995; 20: 161-163.
https://doi.org/10.1111/j.1365-2230.1995.tb02674.x DOI: https://doi.org/10.1111/j.1365-2230.1995.tb02674.x
Teraki Y, Inoue Y. Skin-homing Th2/Th22 cells in papuloerythroderma of Ofuji. Dermatol Basel Switz 2014; 228: 326-331.
https://doi.org/10.1159/000358588 DOI: https://doi.org/10.1159/000358588
Mufti A, Lytvyn Y, Abduelmula A, Kim P, Sachdeva M, Yeung J. Treatment outcomes in patients with papuloerythroderma of Ofuji: a systematic review. JAAD Int 2021; 3: 18-22.
https://doi.org/10.1016/j.jdin.2021.02.001 DOI: https://doi.org/10.1016/j.jdin.2021.02.001
Balestri R, Magnano M, Rech G, Zorzi MG, Girardelli CR. Long-term use of methotrexate in papuloerythroderma of Ofuji. Dermatol Ther 2020; 33: e13219.
https://doi.org/10.1111/dth.13219 DOI: https://doi.org/10.1111/dth.13219
P Patruno C, Fabbrocini G, Longo G, Argenziano G, Ferrucci SM, Stingeni L, et al. Effectiveness and safety of long-term dupilumab treatment in elderly patients with atopic dermatitis: a multicenter real-life observational study. Am J Clin Dermatol 2021; 22: 581-586.
https://doi.org/10.1007/s40257-021-00597-5 DOI: https://doi.org/10.1007/s40257-021-00597-5
Teraki Y, Taguchi R, Takamura S, Fukuda T. Use of dupilumab in the treatment of papuloerythroderma of Ofuji. JAMA Dermatol 2019; 155: 979-980.
https://doi.org/10.1001/jamadermatol.2019.0946 DOI: https://doi.org/10.1001/jamadermatol.2019.0946
Komatsu-Fujii T, Nonoyama S, Ogawa M, Fukumoto T, Tanabe H. Rapid effects of dupilumab treatment on papuloerythroderma of Ofuji. J Eur Acad Dermatol Venereol 2020; 34: e739-e741.
https://doi.org/10.1111/jdv.16581 DOI: https://doi.org/10.1111/jdv.16581
Published
How to Cite
License
Copyright (c) 2024 Clélia Vanhaecke, Laurence Gusdorf, Manuelle Viguier
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
